The category of cancers involving lymph nodes is known as non-Hodgkin lymphoma, as the lymphatic system serves as the foundation for this collection of cancers. The tonsils, spleen, thymus, lymph nodes, lymph vessels, and bone marrow are all parts of the lymphatic system. The body uses these structures to defend against infections while they help maintain immunity.
Lymphocytes, which can develop into non-Hodgkin lymphoma through abnormal growth, may accumulate as malignant cells in lymph nodes or other tissues, forming tumors that affect the immune system.
Hodgkin's lymphoma is identified by the Reed-Sternberg cell. Non-Hodgkin's lymphoma includes various subtypes, each responding differently to treatment. Some types grow slowly, while others grow quickly and need urgent care.
Non-Hodgkin lymphoma may occur at any age, but it is more common in older adults. It generally occurs in the lymph nodes and can spread to the stomach, intestines, skin, brain, or bone marrow.
Recent medical advances have improved diagnosis, targeted treatments, immunotherapy, and stem cell transplants, leading to better outcomes for patients with non-Hodgkin lymphoma.
The lymphatic system comprises organs, tissues, and vessels that are all important for the immune defense of the human body. The system helps remove excess fluids from the body's tissues.
The lymphatic system is made up of:
Lymphocytes circulate through the lymphatic system and the blood circulation to identify and destroy pathogens. Lymphomas arise when lymphocytes undergo mutations that disrupt their proliferation.
There exist over 60 distinct varieties of non-Hodgkin lymphoma. The classification system groups these diseases based on their specific lymphocyte type and cancer growth velocity.
B-cell lymphomas arise from B lymphocytes, which normally produce antibodies that help fight infections. B cells account for about 85-90% of non-Hodgkin lymphoma cases.
The common types are:
The most prevalent type is diffuse large B-cell lymphoma, which grows rapidly but responds well to treatment.
T-cell lymphomas derive from T-cells that serve as regulators in the body's immune response and eliminate pathogens.
Examples include the following:
T-cell lymphomas are less prevalent than B-cell lymphomas, but they can exhibit more aggressive growth behavior in particular instances.
Doctors use growth rate to classify non-Hodgkin lymphoma into two categories.
These slow-growing lymphomas may not cause symptoms for many years. Examples include follicular lymphoma and marginal zone lymphoma.
These lymphomas grow rapidly and require immediate treatment. The two illnesses, diffuse large B-cell lymphoma and Burkitt lymphoma, serve as examples.
Treatment protocols must account for both the lymphoma type and its aggressive cancer behavior.
The site of lymphoma development and the disease stage determine the symptoms patients experience.
Patients usually experience these symptoms:
The symptoms of lymphoma depend on what part of the body is involved.
Patients with symptoms include:
Patients exhibit symptoms known as "B symptoms," including fever, night sweats, and unexplained weight loss. These symptoms indicate that the disease has advanced to a more severe stage.
The precise origins of non-Hodgkin lymphoma remain unknown in some cases. The disease develops through genetic mutations in lymphocytes, which then multiply beyond normal limits.
The body forms tumors when these cells accumulate in lymph nodes and other tissues.
The majority of genetic mutations arise through natural processes that do not involve passing these changes to future generations.
The likelihood of developing non-Hodgkin lymphoma increases due to multiple risk factors.
The risk of wounds and injuries increases with age, particularly after age 60.
People with weakened immune systems, including those who have HIV or have received organ transplants, face higher risks.
Lymphoma development occurs through certain bacterial and viral infections, which include:
The occurrence of rheumatoid arthritis and Sjögren's syndrome usually leads to an increased risk of developing lymphoma.
Prolonged exposure to specific types of chemicals can increase the risk of developing NHL.
There is a higher possibility of developing lymphoma due to high levels of radiation exposure.
Non-Hodgkin Lymphoma is diagnosed through clinical assessment, imaging, and laboratory testing.
The doctor evaluates the patient for signs of disease by examining enlarged lymph nodes and other physical signs.
The most important procedure to diagnose lymphoma is a biopsy.
In this procedure, a lymph node or tissue sample is removed for microscopic examination. The tissue sample is studied to know the type of lymphoma and its characteristics.
These are done to assess a person's overall health and to identify abnormal blood cell counts.
2Imaging studies help determine the extent of the disease.
Common imaging tests include:
The tests identify enlarged lymph nodes and determine whether lymphoma has disseminated to other parts of the body.
A bone marrow biopsy performed by experts helps to determine whether lymphoma has spread to the bone marrow.
Laboratories use advanced testing methods to examine the genetic and molecular characteristics of lymphoma cells.
The tests identify the lymphoma subtype, which helps in making treatment decisions.
Staging describes how far the lymphoma has spread in the body.
The disease staging system establishes four distinct stages.
The lymphatic system shows signs of lymphoma when it is present in a single lymph node area or a single body organ.
More than two lymph node areas on one side of the diaphragm show involvement.
Lymph nodes, situated on both sides of the diaphragm, are affected.
Lymphoma spreads to organs outside the lymphatic system, including bone marrow and the liver.
Additional letters may be used to indicate the presence of systemic symptoms.
The treatment of non-Hodgkin lymphoma requires consideration of multiple factors, including the lymphoma type, disease stage, and patient health condition.
Doctors treating patients with slow-growing lymphomas that lack symptoms will use observation as the primary treatment.
This approach is known as active surveillance.
Chemotherapy opts for effective medication using powerful drugs to kill cancer cells.
It stands as the most prevalent non-Hodgkin lymphoma treatment option, which doctors use alone or together with other treatment approaches.
Immunotherapy strengthens the immune system (immunity) to identify and destroy lymphoma cells.
Monoclonal antibodies are the primary immunotherapies that specifically target proteins on lymphoma cells.
Targeted therapies disrupt the specific molecular pathways that lymphoma cells use to grow and survive.
The drugs succeed in treating specific lymphoma subtypes.
Radiation therapy employs high-energy beams to eliminate cancer cells.
The treatment may address localized disease or provide symptom relief.
Patients who suffer from aggressive lymphoma or experience disease relapse may benefit from stem cell transplantation as a treatment option.
The procedure enables patients to restore their bone marrow function by transplanting healthy stem cells after high-dose chemotherapy.
The CAR T-cell therapy represents a novel treatment that transforms a patient's immune cells to detect and destroy lymphoma cells.
The therapy is a treatment option for certain advanced lymphomas that do not respond to standard approaches.
The medical prognosis for patients with non-Hodgkin lymphoma depends on multiple factors that influence their outlook. The important factors that pertain to the investigation include the following elements:
The majority of patients with non-Hodgkin lymphoma can achieve permanent remission with effective medical treatment. The development of targeted therapy and immunotherapy has resulted in substantial improvements to patient survival rates over the past few years.
The physical and emotional difficulties of lymphoma make daily life challenging for patients. Cancer patients who receive treatment will develop fatigue symptoms, infection problems, and several other treatment-related complications. The three types of supportive care services, including nutritional counseling and psychological support, will help patients face their challenges. The medical staff asks patients to attend follow-up appointments, as this will aid in monitoring their recovery and in assessing their health to detect cancer recurrence.
Tender Palm Super-Speciality Hospital offers advanced Non-Hodgkin Lymphoma treatment in Lucknow, India, at an affordable cost. We have a team of experienced hematologists and oncology specialists who provide accurate diagnosis and both non-surgical and surgical treatment options including chemotherapy, radiation therapy, and immunotherapy. Our Hematology and Oncology team has decades of experience in successfully treating Non-Hodgkin Lymphoma in Lucknow, India.
Call us at +91-9076972161
Email at care@tenderpalm.com